You are here: Industry Insights > Moderna

News List

Moderna signs ten-year vaccine manufacturing deal with Lonza pharmaceutical-technology
May 04, 2020
Moderna has signed a ten-year agreement with Lonza for large-scale manufacture of its vaccine candidate, mRNA-1273, against Covid-19 and other products in the future.
BARDA to give Moderna up to $483 million for COVID-19 vaccine development europeanpharmaceuticalreview
April 22, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) will fund Moderna’s COVID-19 vaccine candidate mRNA-1273 through Phase II and III clinical trials to FDA licensure.
US BARDA commits up to $483m for Moderna Covid-19 vaccine pharmaceutical-technology
April 20, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) has committed up to $483m to support the development of the Moderna mRNA vaccine candidate, mRNA-1273, against Covid-19.
Moderna to pause certain clinical development activities amid Covid-19 pharmaceutical-technology
March 31, 2020
Biotechnology firm Moderna has provided an update on the impact of the Covid-19 pandemic on its clinical development activities and business operations.
Moderna Leads Coronavirus Vaccine Charge contractpharma
March 19, 2020
First participant dosed in NIH-led Phase 1 study of mRNA vaccine against novel coronavirus.
First US clinical trial of Covid-19 vaccine candidate begins pharmaceutical-technology
March 18, 2020
The first US clinical trial of a Covid-19 vaccine candidate, which is Moderna’s mRNA-1273, has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.
First Patient Dosed in Moderna's COVID-19 Vaccine Trial biospace
March 17, 2020
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 began.
Moderna Receives FDA Fast Track Designation for Zika Vaccine biospectrumasia
August 21, 2019
Investigational Zika vaccine (mRNA-1893) is currently being evaluated in a Phase 1 study for the prevention of Zika virus infection in healthy adults
Moderna’s cash juggernaut rolls on with record $604M IPO fiercebiotech
December 28, 2018
Moderna’s IPO always looked like a record breaker for biotech and came in even larger than expected at $604 million, valuing the company at an eye-watering $7.9 billion.....
Secretive Moderna could finally go public with $500m IPO pharmaphorum
December 12, 2018
RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page